tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Benitec Biopharma Inc

BNTC
Add to Watchlist
12.040USD
+0.150+1.26%
Close 07-29 16:00（ET）Quotes delayed by 15 min
316.06MMarket Cap
LossP/E TTM

Benitec Biopharma Inc

12.040
+0.150+1.26%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

BNTC Financials

See Benitec Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Benitec Biopharma Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.24/-0.27
Revenue / Forecast
0.00/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.05
80.99%
Analyst Rating
BUY
2026/07/29
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
0.28%-0.24
22.74%-0.26
54.57%-0.22
34.65%-0.39
85.18%-0.24
87.37%-0.33
82.78%-0.48
78.81%-0.60
38.78%-1.64
20.94%-2.64
65.39%-2.76
---2.83
---2.67
---3.34
---7.98
----
----
----
----
----
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--7.00K
12.50%54.00K
-44.00%14.00K
--0.00
-100.00%0.00
4700.00%48.00K
2400.00%25.00K
-100.00%0.00
--2.00K
Net Profit
-27.59%-11.94M
-60.89%-11.84M
-77.21%-8.96M
-202.43%-16.15M
-118.60%-9.35M
-8.22%-7.36M
15.03%-5.06M
-14.55%-5.34M
2.68%-4.28M
-25.63%-6.80M
-16.91%-5.95M
8.01%-4.66M
-34.26%-4.40M
-12.24%-5.41M
-0.95%-5.09M
-26.58%-5.07M
16.22%-3.27M
-48.25%-4.82M
-85.61%-5.04M
---4.00M
Net Margin
----
----
----
----
----
----
----
----
----
----
----
---66585.71%
---8142.59%
---38650.00%
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
----
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
--0.00%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Income Statement
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--7.00K
12.50%54.00K
-44.00%14.00K
--0.00
-100.00%0.00
4700.00%48.00K
2400.00%25.00K
-100.00%0.00
--2.00K
Operating profit
-33.31%-13.58M
-55.37%-13.38M
-69.28%-9.80M
-209.59%-17.18M
-146.03%-10.19M
-24.30%-8.61M
1.41%-5.79M
-21.93%-5.55M
4.61%-4.14M
-23.48%-6.93M
-28.25%-5.87M
3.97%-4.55M
-25.46%-4.34M
-16.03%-5.61M
5.02%-4.58M
-22.91%-4.74M
8.78%-3.46M
-48.36%-4.83M
-79.26%-4.82M
---3.85M
Net Profit
-27.59%-11.94M
-60.89%-11.84M
-77.21%-8.96M
-202.43%-16.15M
-118.60%-9.35M
-8.22%-7.36M
15.03%-5.06M
-14.55%-5.34M
2.68%-4.28M
-25.63%-6.80M
-16.91%-5.95M
8.01%-4.66M
-34.26%-4.40M
-12.24%-5.41M
-0.95%-5.09M
-26.58%-5.07M
16.22%-3.27M
-48.25%-4.82M
-85.61%-5.04M
---4.00M
Balance Sheet
Current assets
78.85%186.02M
140.87%189.59M
39.14%95.08M
90.65%98.52M
624.00%104.01M
278.50%78.71M
158.73%68.33M
1285.73%51.67M
94.27%14.37M
89.49%20.80M
54.63%26.41M
-22.63%3.73M
-16.36%7.39M
-13.39%10.97M
4.33%17.08M
-76.61%4.82M
-28.74%8.84M
-11.90%12.67M
103.23%16.37M
--20.61M
Total current liabilities
-53.40%3.27M
-9.32%2.80M
-55.52%2.02M
-63.40%1.80M
104.42%7.03M
-46.24%3.09M
0.42%4.55M
23.78%4.92M
9.01%3.44M
130.86%5.75M
50.58%4.53M
57.11%3.98M
65.17%3.15M
0.36%2.49M
88.07%3.01M
84.95%2.53M
-21.89%1.91M
218.36%2.48M
57.11%1.60M
--1.37M
Total assets
77.74%187.00M
141.16%190.68M
39.63%96.03M
90.75%99.59M
601.44%105.21M
270.29%79.07M
154.22%68.77M
1069.58%52.21M
82.47%15.00M
79.36%21.35M
49.34%27.05M
-25.26%4.46M
-18.32%8.22M
-15.05%11.90M
1.56%18.11M
-72.06%5.97M
-25.05%10.06M
-9.66%14.01M
100.04%17.84M
--21.38M
Total liabilities
-51.98%3.67M
6.17%3.32M
-47.15%2.43M
-53.71%2.30M
118.32%7.64M
-46.85%3.13M
-3.18%4.59M
16.42%4.96M
-0.23%3.50M
102.10%5.88M
35.49%4.75M
37.88%4.26M
37.85%3.51M
-8.40%2.91M
48.33%3.50M
125.79%3.09M
1.84%2.54M
258.29%3.18M
100.08%2.36M
--1.37M
Total equity
87.90%183.33M
146.72%187.36M
45.84%93.60M
105.92%97.30M
748.43%97.57M
390.89%75.94M
187.70%64.18M
23290.10%47.25M
144.01%11.50M
72.00%15.47M
52.66%22.31M
-92.99%202.00K
-37.33%4.71M
-17.00%8.99M
-5.57%14.61M
-85.60%2.88M
-31.20%7.52M
-25.91%10.84M
100.04%15.47M
--20.01M
Cash Flow Statement
Net operating income
-44.26%-4.45M
50.98%-3.78M
26.93%-3.35M
-149.41%-8.21M
49.97%-3.09M
-43.58%-7.70M
-0.20%-4.59M
19.58%-3.29M
-53.09%-6.17M
8.18%-5.37M
-13.15%-4.58M
15.65%-4.09M
-17.74%-4.03M
-74.73%-5.84M
5.45%-4.04M
5.86%-4.86M
-72.05%-3.42M
-0.54%-3.34M
-81.27%-4.28M
-63.97%-5.16M
Net investment
-150.00%-15.00K
8.33%-11.00K
--0.00
--0.00
96.65%-6.00K
---12.00K
----
100.00%0.00
---179.00K
--0.00
--0.00
92.31%-1.00K
----
--0.00
--0.00
-109.22%-13.00K
100.00%0.00
100.00%0.00
100.00%0.00
1184.62%141.00K
Net financing
-98.22%506.00K
449.63%98.23M
-100.00%0.00
-93.65%2.54M
--28.41M
45725.64%17.87M
-22.44%21.66M
--40.07M
--0.00
--39.00K
74.33%27.92M
--0.00
--0.00
--0.00
--16.02M
-100.00%0.00
-100.00%0.00
----
----
--12.67M

FAQs

What are the current assets of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2025 earnings report, its current assets were 98.52M, with a year-on-year change of 90.65.

What are the total assets of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2025 earnings report, its total assets of Benitec Biopharma Inc were 99.59M, with a year-on-year change of 90.75.

What are the total liabilities of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2025 earnings report, its total liabilities of Benitec Biopharma Inc were 2.30M, with a year-on-year change of -53.71.

What is the total equity of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2025 earnings report, its total equity of Benitec Biopharma Inc was 97.30M, with a year-on-year change of 105.92.

What is the net operating income of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2025 earnings report, its net operating income of Benitec Biopharma Inc was -41.77M, with a year-on-year change of -85.70.

What is the net investment of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2025 earnings report, its net investment of Benitec Biopharma Inc was -18.00K, with a year-on-year change of 89.94.

What is the net financing of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2025 earnings report, its net financing of Benitec Biopharma Inc was 70.48M, with a year-on-year change of 3.61.

What is the Earnings Per Share (EPS) of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.05, with a year-on-year change of 80.99.

What is the net income of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2025 earnings report, its net income was -37.92M, with a year-on-year change of -69.50.

What is the Return on Equity (ROE) of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -52.46, with a year-on-year change of 44.36.

What is the Return on Assets (ROA) of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -49.96, with a year-on-year change of 34.92.

What is the operating profit of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2025 earnings report, its operating profit was -41.77M, with a year-on-year change of -85.70.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy